Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$2.03B
+0.7% from 2023
Prescriptions
131K
$15,470.96 per claim
Patients
16K
8,687 prescribers
Total spending, 2024
$2.04B
$127,803.94 per patient
Medicare prescription drug plans paid $2.03B for Ibrance in 2024, for 131,483 prescriptions and refills to 15,915 patients (up 0.7% from 2023). The average cost per claim was $15,470.96.
California had the highest Medicare cost for Ibrance in 2024: $248.5M for 16,220 claims, followed by New York ($155.9M).
Luis Baez Vallecillo, hematology-oncology in San Juan, PR, had the highest Medicare cost for Ibrance in 2024: 225 claims costing $3.6M.
Ibrance is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Luis Baez Vallecillo San Juan, PR | Hematology-Oncology | 225 | 24 | $3.6M |
| Nguyet A Le-Lindqwister Peoria, IL | Hematology-Oncology | 205 | 22 | $2.9M |
| Amy C Vander Woude |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 8,769 | 134,769 | 17,488 | $1.95B |
| 2023 | 8,585 | 128,889 | 15,999 | $2.02B |
| 2024 | 8,687 | 131,483 | 15,915 | $2.03B |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 172 |
| 20 |
| $2.6M |
| Monica Mendez Ayala Manati, PR | Hematology-Oncology | 160 | 20 | $2.6M |
| Anna M Di Marco Ponce, PR | Hematology-Oncology | 156 | 19 | $2.5M |
| Christina L Bi Roseville, CA | Pharmacist | 160 | 32 | $2.5M |
| Jason A Incorvati Philadelphia, PA | Medical Oncology | 156 | 17 | $2.5M |
| Stephan B Rosenfeld Fayetteville, AR | Medical Oncology | 142 | 15 | $2.3M |
| Melissa M Everett Buffalo, NY | Physician Assistant | 153 | 26 | $2.2M |
| Ana E Cuesta Fernandez Orlando, FL | Hematology-Oncology | 149 | 20 | $2.2M |
| Heather Yeckes-Rodin Port St. Lucie, FL | Medical Oncology | 137 | 16 | $2.2M |
| Jennifer S Winn Philadelphia, PA | Hematopoietic Cell Transplantation and Cellular Therapy | 135 | 17 | $2.1M |
| Frances A Behrmann Miami, FL | Hematology-Oncology | 135 | 17 | $2.1M |
| Nick C Leasure West Reading, PA | Hematology-Oncology | 138 | 15 | $2.1M |
| Santa M Merle Guaynabo, PR | Hematology-Oncology | 128 | 17 | $2.0M |
| Adnan Al-Khalili Perrysburg, OH | Medical Oncology | 129 | 14 | $2.0M |
| Robert P Fein Somerset, NJ | Hematology-Oncology | 126 | 13 | $2.0M |
| Kristine Lethert Portland, OR | Internal Medicine | 129 | 11 | $2.0M |
| Maria C Aloba El Paso, TX | Hematology-Oncology | 120 | 21 | $2.0M |
| Ellen Szwed Fort Wayne, IN | Hematology-Oncology | 128 | 17 | $2.0M |
| Bryan Lee Springfield, MA | Hematology-Oncology | 127 | 13 | $1.9M |
| Rowena D Meyer Duarte, CA | Nurse Practitioner | 129 | 16 | $1.9M |
| David R Drosick Cincinnati, OH | Medical Oncology | 124 | 14 | $1.9M |
| Gabrielle Rocque Birmingham, AL | Diagnostic Radiology | 123 | 16 | $1.9M |
| Brent N Rexer Nashville, TN | Medical Oncology | 124 | 18 | $1.9M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Pfizer US Pharm PFE | 131,537 | $2.04B |